Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

Starting soon · Phase 3

Conditions studied: Post Partum Haemorrhage

In brief

Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.

Key facts

Study ID

NCT07474077

Run by

Sultan Qaboos University

People needed

88

Starts

2026-05-01

Expected to finish

2028-03-31

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant woman with risk factors for postpartum haemorrhage undergoing elective and emergency caesarean section in SQUH.
• Previous Caesarean Section
• Multiple pregnancy,
• Polyhydramnios,
• Fetal macrosomia (BW \>4kg),
• Anemia
• Booking BMI>30
• Previous history of postpartum hemorrhage
• Fibroids,
• Adenomyosis,
• Placenta previa (non- accreta),
• Chorioamnionitis.
• Exclusion Criteria: Woman with conditions like
• Placenta accreta spectrum,
• Contraindications to tranexamic acid (e.g., hypersensitivity to tranexamic acid), -History of seizure disorders,
• Kidney disease,
• Thromboembolic disease,
• Medical conditions or treatments associated with a high risk of thrombosis

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.